Skip to main content
AmigoFish

Episode 147: Myeloma Series, Pt. 7 - Transplant Consolidation for Multiple Myeloma (2026)

From The Fellow on Call: The Heme/Onc Podcast ·

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This week, we discuss the role of the “consolidation” phase of treatment in multiple myeloma, focusing on three key trials: IFM 2009, DETERMINATION, and the MIDAS Trial.

Content:

- What is the role of autologous stem cell transplant in the management of multiple myeloma?

- How did we get to our current standards of care?

- How is minimal residual disease (MRD) fitting into our treatment paradigm?

** This episode is sponsored by Primum! To learn more, sign up for your free account, and to ask questions to Primum experts, visit primum.co/fellows (http://primum.co/fellows)

** Want to review the show notes for this episode and others? Check out our website.

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Youtube

Back to The Fellow on Call: The Heme/Onc Podcast · Report a problem